Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Change in Acquisitions & Divestments (2020 - 2025)

Maxcyte (MXCT) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with $38.2 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments rose 23.1% to $38.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $155.8 million through Dec 2025, down 2.31% year-over-year, with the annual reading at $155.8 million for FY2025, 2.31% down from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $38.2 million at Maxcyte, down from $40.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $200.8 million in Q1 2022, with the low at $6.0 million in Q3 2021.
  • Average Change in Acquisitions & Divestments over 5 years is $52.2 million, with a median of $43.0 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments soared 1154.97% in 2022, then crashed 61.29% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at $55.5 million in 2021, then decreased by 5.41% to $52.5 million in 2022, then rose by 26.19% to $66.2 million in 2023, then plummeted by 53.21% to $31.0 million in 2024, then grew by 23.1% to $38.2 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $38.2 million, $40.0 million, and $31.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.